Effectiveness of Hyperbaric Oxygen Therapy in Adults

NCT ID: NCT06284603

Last Updated: 2024-02-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2023-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this controlled, experimental study is to learn about the effects of 10 sessions of hyperbaric oxygen therapy on physical performance, vascular circulation, biochemical parameters, and composition of the intestinal microbiota in young healthy men depending on the frequency of single treatments.

The main questions it aims to answer are:

1. Do 10 treatments of hyperbaric oxygen therapy induce significant changes in physical performance levels, vascular circulation, and concentrations of biochemical parameters in young, healthy men?
2. Does the body's response to 10 treatments of hyperbaric oxygen therapy differ depending on the frequency of treatments?
3. Does a series of hyperbaric oxygen therapy treatments induce significant changes in the composition of the intestinal microbiota, metabolome, and functional status of the intestines?

Participants are exposed to hyperoxia under hyperbaric conditions or form a control group with no treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two study groups (dependent on frequency of HBOT treatments) and control group
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group 1: HBOT 3/week

The protocol comprises 10 Hyperbaric Oxygen Treatments (HBOT), 3 sessions per week.

Group Type ACTIVE_COMPARATOR

Hyperbaric Oxygen Therapy - HBOT

Intervention Type DEVICE

Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes

Study Group 2: HBOT 6/week

The protocol comprises 10 Hyperbaric Oxygen Treatments (HBOT), 6 sessions per week.

Group Type ACTIVE_COMPARATOR

Hyperbaric Oxygen Therapy - HBOT

Intervention Type DEVICE

Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes

Control Group

No changes to a daily routine.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyperbaric Oxygen Therapy - HBOT

Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-35;
* Healthy, physically active men;
* Subject who is knowingly willing to participate in the study;
* Subject able to read, understand and sign an informed consent to participate.

Exclusion Criteria

* Inability to attend scheduled visits and/or follow study protocol;
* Use of HBOT prior to study inclusion;
* Severe or unstable physical impairment or severe cognitive deficits at study entry;
* Pressure-sensitive chest diseases (including moderate or severe asthma) or pressure-sensitive ear or sinus diseases;
* Active smoking;
* Having suffered an injury within 3 months up to the date of the study;
* Taking pre- and/or probiotics in the last 3 months before the study;
* Inpatient hospital or emergency room stay in the last 4 weeks prior to study entry;
* Travel to tropical countries during the last 4 weeks prior to the study;
* Taking antibiotics, steroids and steroid-anabolic agents during the last 4 weeks before the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poznan University of Physical Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara Pospieszna, PhD.

Role: PRINCIPAL_INVESTIGATOR

Department of Athletics, Strength and Conditioning, Poznan Univ of Physical Ed, Poznan, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Poznan University of Physical Education

Poznan, Wielkopolska, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AWF_LA_HBOT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.